BAP29 Peptide
Code | Size | Price |
---|
PSI-3667P-0.05mg | 0.05mg | £166.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Target Species: Human
Documents
Further Information
Additional Names:
BAP29, BAP29, B-cell receptor-associated protein 29, BCR-associated protein 29
Application Note:
BAP29 peptide is used for blocking the activity of BAP29 antibody.
Background References:
- Kim KM, Adachi T, Nielsen PJ, et al. Two new proteins preferentially associated with membrane immunoglobulin D. EMBO J. 1994; 13:3793-800.
- Bertolotti A, Zhang Y, Hendershot LM, et al. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat. Cell Biol. 2000; 2:326-32.
- Shen J, Chen X, Hendershot L, et al. ER stress regulation of ATF6 localization by dissociation of BiP/GRP78 binding and unmasking of Golgi localization signals. Dev. Cell 2002; 3:99-111. 5. Lee K, Tirasophon W, X Shen, et al. IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response. Genes Dev. 2002; 16:452-66. 6. Miyoshi K, Katayama T, Imaizumi K, et al. Characterization of mouse Ire1 α: cloning, mRNA localization in the brain and functional analysis in a neural cell line. Brain Res. Mol. Brain Res. 2000; 85:68-76.
Buffer:
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide
Concentration:
200 ug/mL
NCBI Gene ID #:
55973
NCBI Official Name:
B-cell receptor-associated protein 29
NCBI Official Symbol:
BCAP29
NCBI Organism:
Homo sapiens
Peptide aa Location:
17 amino acids near the center of human BAP29.
Physical State:
Liquid
Protein Accession #:
NP_001008405
Protein GI Number:
56549093
Swissprot #:
Q9UHQ4
Related Products
Product Name | Product Code | Supplier | BAP29 Antibody | PSI-3667 | ProSci | Summary Details | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|